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Injectable phenytoin loaded polymeric microspheres for the control of temporal
lobe epilepsy in rats
Abstract
Epilepsy is a prevalent neurological disorder with a high frequency of drug resistance. While significant
advancements have been made in drug delivery systems to overcome anti-epileptic drug resistance,
efficacies of materials in biological systems have been poorly studied. The purpose of the study was to
evaluate the anti-epileptic effects of injectable poly(epsiloncaprolactone) (PCL) microspheres for
controlled release of an anticonvulsant, phenytoin (PHT), in an animal model of epilepsy. Methods: PHTPCL and Blank-PCL microspheres formulated using an oil-in-water (O/W) emulsion solvent evaporation
method were evaluated for particle size, encapsulation efficiency, surface morphology and in-vitro drug
release profile. Microspheres with the most suitable morphology and release characteristics were
subsequently injected into the hippocampus of a rat tetanus toxin model of temporal lobe epilepsy.
Electrocorticography (ECoG)from the cerebral cortex were recorded for all animals. The number of
seizure events, severity of seizures, and seizure duration were then compared between the two treatment
groups. Results: We have shown that small injections of drug-loaded microspheres are biologically
tolerated and released PHT can control seizures for the expected period of time that is in accord with invitro release data. Conclusion: The study demonstrated the feasibility of polymer-based delivery systems
in controlling focal seizures.
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Abstract.
Purpose: Epilepsy is a prevalent neurological disorder with a high frequency of drug resistance. While significant advancements have been made in drug delivery systems to overcome anti-epileptic drug resistance, efficacies of materials in biological
systems have been poorly studied. The purpose of the study was to evaluate the anti-epileptic effects of injectable poly(epsiloncaprolactone) (PCL) microspheres for controlled release of an anticonvulsant, phenytoin (PHT), in an animal model of epilepsy.
Methods: PHT-PCL and Blank-PCLmicrospheres formulated using an oil-in-water(O/W) emulsion solvent evaporation method
were evaluated for particle size, encapsulation efficiency, surface morphology and in-vitro drug release profile. Microspheres
with the most suitable morphology and release characteristics were subsequently injected into the hippocampus of a rat tetanus
toxin model of temporal lobe epilepsy. Electrocorticography (ECoG)from the cerebral cortex were recorded for all animals. The
number of seizure events, severity of seizures, and seizure duration were then compared between the two treatment groups.
Results: We have shown that small injections of drug-loaded microspheres are biologically tolerated and released PHT can
control seizures for the expected period of time that is in accord with in-vitro release data.
Conclusion: The study demonstrated the feasibility of polymer-based delivery systems in controlling focal seizures.
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1. Introduction
Advances in biomaterial science over the past
decades have resulted in a dramatic expansion in the
*Corresponding author: Dr. Jonathan L. Jiang, St Vincent's
Department of Medicine, University of Melbourne, Fitzroy, VIC
3065, Australia. Tel.: +61 3 9288 3517: Fax: +61 3 9288 3350:
E-mail: jonathan.jiang@ unimelb.edu.au.

use of polymer-based drug delivery systems (Halliday & Cook, 2009; Halliday et al., 2012). In addition
to applications in management of cancers and diabetes (Gallia et al., 2005; Traitel et al., 2000), multiple
animal studies have demonstrated successes in using
polymer based implants to treat neurological disorders
including Parkinson's disease, Huntington's disease
and Alzheimer's disease (Halliday & Cook, 2009).
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